{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1110.50","meta":{"versionId":"20","lastUpdated":"2022-02-19T01:06:51.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50","version":"20220219","name":"Rivaroxaban for VTE Prophylaxis","status":"active","date":"2022-02-19T01:06:51-05:00","publisher":"TJC EH Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1114198","display":"rivaroxaban 10 MG Oral Tablet"},{"code":"1232082","display":"rivaroxaban 15 MG Oral Tablet"},{"code":"1232086","display":"rivaroxaban 20 MG Oral Tablet"},{"code":"1549682","display":"{42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack"},{"code":"2059015","display":"rivaroxaban 2.5 MG Oral Tablet"},{"code":"2588062","display":"rivaroxaban 155 MG Granules for Oral Suspension"}]}]}}